Achieving Remission Maintenance in AML

J

Oral Azacitidine in AML: Results from QUAZAR-AML-001 Trial

By Jane Liesveld
230 views
July 9, 2024
Comments 0
Login to view comments. Click here to Login
19:01

Debates in AML: 7+3 Is No Longer the Standard of Care

XV Eurasian Hematology-Oncology Congress - EHOC 2024

T. Kadia

651 views
14:21

New

Secondary AML: Best Therapy Options

Weill Cornell Medicine Oncology & Hematology

P. Desai

106 views
07:07

ESMO 2024 Summary: IDH Mutated AML - Diagnostic and Treatment Paradi…

2024 ESMO Annual Meeting Insights Hub

T. Macarulla Mercade

53 views
27:49

AML, MDS, and CML Highlights & Key Takeaways From ASCO®/EHA 2024

Insights from 2024 EHA Annual Meeting

T. Badar

720 views
34:34

Current & Emerging Therapies for AML and MDS

Indy Hematology Review

R. Komrokji

112 views
11:35

Prevention and Management of Post-SCT Relapse in Acute Leukemias

Vanderbilt University Medical Center (VUMC)

A. Jallouk

254 views
25:57

Managing Intensive-Chemotherapy Ineligible Patients With AML

Scripps Health

C. DiNardo

158 views
18:44

Current and Emerging Treatment Approaches for Patients With AML or M…

University of Miami Sylvester Comprehensive Cancer Center

S. Venugopal

132 views
14:19

Challenges in the Management of TP53-Mutated AML: Potential Strategi…

Talha Badar

451 views
22:26

Management of AML in Older Patients

XV Eurasian Hematology-Oncology Congress - EHOC 2024

F. Ravandi

199 views
24:31

Current Treatment Landscape in Myeloid Malignancies

Houston Methodist

S. Shah

57 views
13:23

Current Role of Maintenance Therapy in AML

Alice Mims

169 views
19:21

Understanding the NPM1 Mutation in AML: Dr. Jekyll and Mr. Hyde

SOHO Brazil 2024

J. Lancet

523 views
27:26

Where I Use Azacitidine and Venetoclax in AML: Present and Future

SOHO Brazil 2024

J. Lancet

466 views
21:20

The Future Paradigm of HMA + Ven or Targeted Agents in AML: Sequenci…

Insights from 2023 ASH Annual Meeting

J. Watts

176 views
27:28

AML: Current Treatment Landscape and Key Recent Updates

UChicago Medicine

A. Patel

384 views
16:11

Experts Discuss the Use of Targeted Therapies in AML

MyCancerHaven

R. Vij, E. Wang

222 views
12:15

Using Transplant in Patients With p53 Mutant MDS or AML

Moffitt Cancer Center

H. Elmariah

329 views
38:10

Experts Discuss How to Approach Frontline Treatment of Unfit Patient…

MyCancerHaven

R. Vij, J. Yang

105 views
19:51

A 50-Year Personal Perspective on the Treatment of AML

XIV Eurasian Hematology-Oncology Congress - EHOC 2023

C. Schiffer

165 views
11:17

State of the Art: Role of Maintenance Therapy in AML

XIV Eurasian Hematology-Oncology Congress - EHOC 2023

Z. Aziz

230 views
18:42

Key Updates in AML, MDS, & MF From ASH

Memorial Sloan Kettering Cancer Center

A. Goldberg

299 views
23:15

Is Post-HSCT Maintenance the SOC for AML?

Rush University Medical Center

M. Levis

302 views
20:33

The Gold Standard in the Use of FLT3 and IDH Inhibitors in AML

SOHO Brazil 2024

J. Lancet

135 views
09:31

The Role of Hypomethylating Agent Maintenance in AML

Yale Cancer Center

R. Shallis

117 views
12:00

EHA 2024 Insights: QUAZAR AML-001 - Oral Azacitidine Maintenance in …

Insights from 2024 EHA Annual Meeting

M. Teresa Voso

87 views
08:58

Importance of AML Maintenance Therapy

Gautam Borthakur

201 views
21:31

Optimal Use of Targeted Therapy for the Elderly or Unfit AML Patient

Moffitt Cancer Center

O. Chan

109 views